Jean Bennett
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Affilié au moment de l'attribution du prix
Philadelphia, États-Unis
La reconnaissance d'un travail ayant un impact durable
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Philadelphia, États-Unis